发明名称 |
Intra-Operative Cancer Diagnosis Based on a Hyperpolarized Marker |
摘要 |
The present invention is concerned with an in vitro method of diagnosing cancer in a tissue sample, wherein said tissue sample is obtained from a patient undergoing cancer surgery. The method described herein is based on a hyperpolarized marker, which is contacted with the tissue sample, and an NMR spectrum and/or an MR image obtained of the tissue sample after having been contacted with the hyperpolarized marker. |
申请公布号 |
US2015133341(A1) |
申请公布日期 |
2015.05.14 |
申请号 |
US201314399240 |
申请日期 |
2013.05.07 |
申请人 |
ALBEDA INNOVATIONS APS |
发明人 |
Lerche Mathilde;Karlsson Magnus;Jensen Pernille Rose |
分类号 |
G01N33/84;G01N33/50 |
主分类号 |
G01N33/84 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of diagnosing a cancer metastasis in a lymph node tissue sample, wherein said method is carried out on an excised lymph node tissue sample obtained from a patient suffering from cancer and wherein said method comprises the following steps:
a) Contacting said tissue sample with a combination of (i) a hyperpolarized metabolic marker indicating metabolically active cells and (ii) a hyperpolarized metabolic marker allowing a distinction between lymphocytes and cancer cells; b) Obtaining an NMR spectrum and/or an MR image of the metabolic products of (i) and (ii) comprised in said tissue sample; c) Determining the ratio rS of the metabolic products of (i) to the metabolic products of (ii); d) Comparing the ratio rS obtained in step c) to a reference ratio rR of the metabolic products of (i) to the metabolic products of (ii) obtained in a lymph node tissue sample consisting of healthy cells; and e) Assigning cancer to said tissue sample based on the comparison carried out in step d), wherein a difference in the ratio rS to the ratio rR indicates the presence of a cancer metastasis in said tissue sample. |
地址 |
Copenhagen DK |